The DIAMOND trial (clinicaltrials.gov Identifier: NCT02282397), involving participants with diabetes aged >60 years who were using multiple daily insulin injections, assigned participants to either CGM or SMBG. This evidence concerns the gene INS and diabetes mellitus.